SASH3 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
natural killer cell	29 studies	32% ± 16%	Explore
B cell	20 studies	29% ± 18%	Explore
CD8-positive, alpha-beta T cell	18 studies	32% ± 13%	Explore
memory B cell	17 studies	24% ± 5%	Explore
non-classical monocyte	15 studies	30% ± 15%	Explore
naive B cell	15 studies	24% ± 6%	Explore
regulatory T cell	15 studies	32% ± 18%	Explore
mature NK T cell	14 studies	32% ± 13%	Explore
CD16-positive, CD56-dim natural killer cell, human	14 studies	38% ± 15%	Explore
classical monocyte	13 studies	28% ± 11%	Explore
CD4-positive, alpha-beta T cell	13 studies	21% ± 8%	Explore
CD16-negative, CD56-bright natural killer cell, human	12 studies	33% ± 15%	Explore
gamma-delta T cell	12 studies	30% ± 8%	Explore
CD8-positive, alpha-beta memory T cell	11 studies	32% ± 21%	Explore
T cell	10 studies	27% ± 10%	Explore
plasmacytoid dendritic cell	10 studies	23% ± 7%	Explore
mucosal invariant T cell	9 studies	25% ± 5%	Explore
effector memory CD8-positive, alpha-beta T cell	7 studies	23% ± 8%	Explore
monocyte	6 studies	33% ± 20%	Explore
conventional dendritic cell	6 studies	40% ± 27%	Explore
dendritic cell	6 studies	40% ± 26%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	6 studies	22% ± 5%	Explore
CD4-positive, alpha-beta memory T cell	5 studies	28% ± 7%	Explore
exhausted T cell	5 studies	36% ± 4%	Explore
precursor B cell	5 studies	33% ± 8%	Explore
macrophage	5 studies	33% ± 30%	Explore
pro-B cell	4 studies	29% ± 8%	Explore
immature B cell	4 studies	29% ± 9%	Explore
effector CD4-positive, alpha-beta T cell	4 studies	34% ± 3%	Explore
effector CD8-positive, alpha-beta T cell	4 studies	41% ± 9%	Explore
effector memory CD4-positive, alpha-beta T cell	4 studies	22% ± 5%	Explore
effector memory CD8-positive, alpha-beta T cell, terminally differentiated	4 studies	28% ± 7%	Explore
plasma cell	3 studies	43% ± 23%	Explore
hematopoietic precursor cell	3 studies	25% ± 8%	Explore
plasmablast	3 studies	35% ± 13%	Explore
lymphocyte	3 studies	23% ± 5%	Explore
myeloid cell	3 studies	22% ± 3%	Explore
innate lymphoid cell	3 studies	53% ± 28%	Explore
T follicular helper cell	3 studies	25% ± 7%	Explore
germinal center B cell	3 studies	32% ± 6%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	3 studies	18% ± 1%	Explore
group 3 innate lymphoid cell	3 studies	27% ± 6%	Explore
double negative thymocyte	3 studies	37% ± 11%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
peripheral blood	12 studies	25% ± 5%	Explore
lymph node	3 studies	24% ± 7%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
lung	100%	2323.94	578 / 578	94%	24.23	1087 / 1155
breast	87%	506.79	400 / 459	94%	21.00	1047 / 1118
stomach	78%	409.90	280 / 359	84%	18.44	241 / 286
intestine	81%	1336.72	781 / 966	80%	15.55	424 / 527
bladder	86%	586.81	18 / 21	69%	14.08	346 / 504
prostate	84%	503.07	206 / 245	65%	6.59	325 / 502
thymus	65%	448.31	427 / 653	75%	39.89	455 / 605
uterus	58%	223.36	98 / 170	80%	12.34	368 / 459
esophagus	58%	266.48	842 / 1445	77%	9.86	140 / 183
kidney	46%	351.57	41 / 89	88%	20.71	792 / 901
brain	31%	149.68	822 / 2642	92%	22.69	650 / 705
adrenal gland	91%	585.41	236 / 258	30%	2.54	70 / 230
liver	64%	258.84	144 / 226	50%	6.36	201 / 406
pancreas	24%	107.00	80 / 328	87%	21.22	154 / 178
ovary	28%	102.59	51 / 180	74%	10.54	318 / 430
lymph node	0%	0	0 / 0	100%	356.13	29 / 29
peripheral blood	100%	14835.01	929 / 929	0%	0	0 / 0
spleen	100%	11145.99	241 / 241	0%	0	0 / 0
adipose	96%	835.96	1161 / 1204	0%	0	0 / 0
skin	14%	45.21	251 / 1809	80%	26.38	378 / 472
tonsil	0%	0	0 / 0	91%	36.46	41 / 45
blood vessel	61%	408.87	811 / 1335	0%	0	0 / 0
heart	33%	129.93	286 / 861	0%	0	0 / 0
eye	0%	0	0 / 0	30%	3.87	24 / 80
muscle	2%	6.15	17 / 803	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0
ureter	0%	0	0 / 0	0%	0	0 / 1

III. Associated gene sets

GO_0042102	Biological process	positive regulation of T cell proliferation
GO_0002726	Biological process	positive regulation of T cell cytokine production
GO_0002639	Biological process	positive regulation of immunoglobulin production
GO_0032753	Biological process	positive regulation of interleukin-4 production
GO_0042098	Biological process	T cell proliferation
GO_0001782	Biological process	B cell homeostasis
GO_0032733	Biological process	positive regulation of interleukin-10 production
GO_0032743	Biological process	positive regulation of interleukin-2 production
GO_0048873	Biological process	homeostasis of number of cells within a tissue
GO_0030890	Biological process	positive regulation of B cell proliferation
GO_0002821	Biological process	positive regulation of adaptive immune response
GO_0042100	Biological process	B cell proliferation
GO_0032729	Biological process	positive regulation of type II interferon production
GO_0043372	Biological process	positive regulation of CD4-positive, alpha-beta T cell differentiation
GO_0046622	Biological process	positive regulation of organ growth
GO_0032760	Biological process	positive regulation of tumor necrosis factor production
GO_0043367	Biological process	CD4-positive, alpha-beta T cell differentiation
GO_0005737	Cellular component	cytoplasm
GO_0005634	Cellular component	nucleus

IV. Literature review

[source]

Gene name	SASH3
Protein name	SAM and SH3 domain-containing protein 3 (SH3 protein expressed in lymphocytes homolog)
Synonyms	SLY CXorf9
Description	FUNCTION: May function as a signaling adapter protein in lymphocytes. .
Accessions	O75995 ENST00000356892.4

SASH3 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review